Effects of human insulin and insulin aspart preparations on levels of IGF-I, IGFBPs and IGF bioactivity in patients with type 1 diabetes

BACKGROUND: Insulin aspart (IAsp) and its biphasic preparations BIAsp50 and BIAsp70 (containing 50% and 70% IAsp, respectively) have distinct glucose-lowering properties as compared to human insulin (HI). We investigated whether this affected the circulating IGF-system which depends on the hepatic i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Zhulin, Christiansen, Jens Sandahl, Laursen, Torben, Wu, Chunsen, Lauritzen, Torsten, Parkner, Tina, Frystyk, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986432/
https://www.ncbi.nlm.nih.gov/pubmed/24725803
http://dx.doi.org/10.1186/1472-6823-14-35

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986432/
https://www.ncbi.nlm.nih.gov/pubmed/24725803
http://dx.doi.org/10.1186/1472-6823-14-35

Ejemplares similares